Skip to content

Clinical Efficacy of Supraclavicular Block for Arthroscopic Shoulder Surgery

Comparison Between Ultrasound-guided Supraclavicular and Interscalene Brachial Plexus Blocks in the Patients Undergoing Arthroscopic Shoulder Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01958801
Enrollment
104
Registered
2013-10-09
Start date
2013-09-30
Completion date
2014-03-31
Last updated
2014-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Horner's Syndrome

Keywords

Supraclavicular brachial plexus block, Interscalene brachial plexus block, Arthroscopic shoulder surgery

Brief summary

The aim of this study is to compare the efficacy of supraclavicular and interscalene brachial plexus blocks in the patients undergoing arthroscopic shoulder surgery.

Detailed description

This study aims to compare supraclavicular brachial plexus block to interscalene brachial plexus block with regard to degree of sensory and motor blockades, side effects and complications of the blocks, and frequency of intraoperative analgesics or antihypertensives use.

Interventions

Redirection of the needle is allowed when spread of local anesthetics does not surround the brachial plexus appropriately and involuntary movement of the forearm or hand is not necessary to confirm the correct placement of the needle.

OTHERInterscalene block

Redirection of the needle is allowed when spread of local anesthetics does not surround the brachial plexus appropriately and involuntary movement of the forearm or hand is not necessary to confirm the correct placement of the needle.

Sponsors

Daegu Catholic University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* American Society of Anesthesiologists physical status I-II * Body mass index \< 35 kg/m2

Exclusion criteria

* Neurologic deficits on the side to be blocked * Infection or inflammation at the puncture site for brachial plexus block * Psychiatric disorders * Patient refusal * Difficulty to communicate * Coagulation deficiencies

Design outcomes

Primary

MeasureTime frameDescription
Degree of sensory blockade20 minutes after the end of local anesthetics injectionSensory blockade of the C5 to T1 dermatomes was assessed by rating the absence of cold sensation between 100 (intact sensation) and 0 (no sensation) with an alcohol swab.

Secondary

MeasureTime frameDescription
Degree of motor blockade20 minutes after the end of local anethetics injectionMotor blockade was evaluated by elbow and wrist extension (radial nerve), finger abduction (ulnar nerve), wrist flexion (median nerve), and elbow flexion (musculocutaneous nerve). The muscle force was rated on a scale of 0 to 6 as follows (6: normal muscle force; 5: slightly reduced muscle force; 4: greatly reduced muscle force; 3: slightly impaired mobility; 2: greatly impaired mobility; 1: near complete paralysis; 0: complete paralysis).
Side effects20 minutes after the end of local anethetics injectionHorner's syndrome (ptosis, miosis, anhidrosis) Subjective dyspnea Hoarseness
Frequency of intraoperative analgesics or antihypertensives useAt the end of the surgeryFrequency of intraoperative use of opioids (fentanyl) or antihypertensives (hydralazine)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026